Efficacy and Safety of Chinese Herbal HuoXue LiShui Formula for Chronic Subdural Hematoma

NANot yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

March 28, 2026

Conditions
Chronic Subdural Hematoma
Interventions
DRUG

Chinese Herbal formula HuoXue LiShui

The intervention consists of the oral administration of granule with either HXLS or a placebo substance, one bag (28.5 g) twice daily after meals for a period of 8 weeks. The granules are produced from four Chinese herbal pieces: Yi Mu Cao (Leonuri Herbal, 15.0g), Zhi Shui Zhi (Hirudo, 1.5g), Tao Ren (Semen persicae, 6.0g), and Hong Hua (Carthami Flos, 6.0g).

DRUG

Chinese Herbal formula Placebo

The placebo will be consistent with the HXLS oral granules in appearance, taste, and weight, to the greatest extent possible. In terms of outer packing, the HXLS and placebo granules will be exactly the same. It included Hu Jing (28.5g)

Trial Locations (3)

100070

Beijing Tiantan Hospital, Capital Medical University, Beijing

101100

Beijing Luhe Hospital, Capital Medical University, Beijing

Unknown

First People's Hospital of Lianyungang, Lianyungang

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06427980 - Efficacy and Safety of Chinese Herbal HuoXue LiShui Formula for Chronic Subdural Hematoma | Biotech Hunter | Biotech Hunter